Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · November 19, 2014

Infliximab Concentrations and Antibodies to Infliximab Impact Disease Activity in Crohn's Disease



Additional Info

The Relationship Between Infliximab Concentrations, Antibodies to Infliximab and Disease Activity in Crohn's Disease
Gut 2014 Oct 21;[EPub Ahead of Print], N Vande Casteele, R Khanna, BG Levesque, L Stitt, GY Zou, S Singh, S Lockton, S Hauenstein, L Ohrmund, GR Greenberg, PJ Rutgeerts, A Gils, WJ Sandborn, S Vermeire, BG Feagan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading